Gut microbiome of Moroccan colorectal cancer patients

Abstract

Although colorectal cancer is the third leading cause of death in Morocco, there are no studies of the microbiome changes associated with the disease in the Moroccan population. The aim of our study was to compare the stool microbiome of Moroccan cancer patients with healthy individuals. We analyzed the microbiome composition of samples from 11 CRC patients and 12 healthy individuals by 16S rRNA amplicon sequencing. Principal coordinate analysis of samples revealed defined cancer versus healthy clusters. Our findings showed that cancer samples had higher proportions of Firmicutes ( T = 50.5%; N = 28.4%; p = 0.04), specifically of Clostridia ( T = 48.3%; N = 19.0%; p = 0.002), and Fusobacteria ( T = 0.1%; N = 0.0%; p = 0.02), especially of Fusobacteriia ( T = 0.1%; N = 0.0%; p = 0.02), while Bacteroidetes were enriched in healthy samples ( T = 35.1%; N = 62.8%; p = 0.06), particularly the class Bacteroidia ( T = 35.1%; N = 62.6%; p = 0.06). Porphyromonas, Clostridium, Ruminococcus, Selenomonas, and Fusobacterium were significantly overrepresented in diseased patients, similarly to other studies. Predicted functional information showed that bacterial motility proteins, flagellar assembly, and fatty acid biosynthesis metabolism were significantly overrepresented in cancer patients, while amino acid metabolism and glycan biosynthesis were overrepresented in controls. This suggests that involvement of these functional metagenomes is similar and relevant in the carcinogenesis process, independent of the origin of the samples. Results from this study allowed identification of bacterial taxa relevant to the Moroccan population and encourages larger studies to facilitate population-directed therapeutic approaches.

Electronic supplementary material

The online version of this article (10.1007/s00430-018-0542-5) contains supplementary material, which is available to authorized users.